{
    "2020-09-18": [
        [
            {
                "time": "2020-09-18",
                "original_text": "药明康德：HCII WX (HK) Holdings Limited 合计完成减持2378.88万股公司股份 减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "减持",
                        "HCII WX",
                        "2378.88万股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-09-18",
                "original_text": "药明康德：股东累计通过大宗交易减持1%股份，完成减持计划 减持股份数量",
                "features": {
                    "keywords": [
                        "药明康德",
                        "股东",
                        "大宗交易",
                        "减持1%"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-09-18",
                "original_text": "药明康德：HCIII WX (HK) Holdings Limited减持完毕 累计减持1%股份 减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "HCIII WX",
                        "减持完毕",
                        "1%股份"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-09-18",
                "original_text": "野村：首予药明康德港股“买入”评级，目标价129港元",
                "features": {
                    "keywords": [
                        "野村",
                        "药明康德",
                        "买入评级",
                        "129港元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}